BioMarin ( BMRN ): Q4 EPS of -$0.11 beats by $0.24 . Non-GAAP Revenue of $148.5M (+13.2% Y/Y) beats by $17.3M . Press Release Post your comment!
By ONeil Trader : Executive summary: NPS Pharmaceuticals' ( NPSP ) successful launch of Gattex and plans for international expansion put the company on a path to significant growth. Natpara is expected to be approved by the end of 2014 with potential peak sales exceeding Gattex's. NPSP795 is the ...
A week after the FDA approved the use of BioMarin's ( BMRN +5.4% ) Vimizim for treating Morquio A syndrome, the European Medicines Agency has issued a positive opinion on BioMarin's
By Don Dion : The 25 day SEC-enforced quiet period on underwriter research, following Ultragenyx Pharmaceutical Inc ( RARE )'s January 30 IPO, will come to an end on Monday, February 24. The conclusion of the quiet period will permit the IPO underwriters to publish positive research on RARE, likely
BioMarin's ( BMRN -0.5% ) Vimizim becomes the 2nd treatment for Morquio A syndrome approved by the FDA this week. The nod isn't a surprise after nearly getting a near-unanimous thumbs up at the Ad Com two months ago. Press release Post your comment!
By Don Dion : UniQure BV ( QURE ), a leading gene therapy biopharmaceutical firm, with principal offices in Amsterdam, plans to raise $64 million in its upcoming IPO. The firm will offer 4.6 million shares at an expected price range of $13-$15 per share. If the IPO can reach the midpoint of that ...
By Don Dion : The RARE IPO Deal Ultragenyx Pharmaceutical ( RARE ), a development-stage biopharm firm, focused on the development of treatments for rare and ultra-rare diseases, plans to raise $94 million in its upcoming IPO on Friday, January 31. The Novato, California-based firm will offer 4.8 ...
think there will be huge charges because of the lawsuits. It is the best performer of the large cap oils. This is the one to buy of the majors." BioMarin ( BMRN ), Biogen Idec ( BIIB ), Gilead ( GILD ): "I think BMRN can Complete Story »
reviewed it after it fell apart. The stock is a wild trader, but the business is secure. We are not backing away." BioMarin ( BMRN ), NPS Pharmaceuticals ( NPSP ): Cramer prefers these stocks to MannKind. Genuine Parts ( GPC ): "It is a very good, consistent
HVAC (heating, ventilation and air conditioning) is one of the strongest currents right now in the action." BioMarin ( BMRN ): "They did a financing, and that has knocked the stock down. I still like that stock." FedEx ( FDX ), UPS ( UPS